• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care.导致心力衰竭失代偿的诱发因素、在基层医疗机构就诊的心力衰竭患者的短期发病率和死亡率。
Scand J Prim Health Care. 2020 Dec;38(4):473-480. doi: 10.1080/02813432.2020.1844387. Epub 2020 Nov 17.
2
Precipitating factors of heart failure admission: Differences related to age and left ventricular ejection fraction.心力衰竭入院的诱发因素:与年龄和左心室射血分数相关的差异
Int J Cardiol. 2016 Sep 15;219:150-5. doi: 10.1016/j.ijcard.2016.06.040. Epub 2016 Jun 15.
3
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.心力衰竭住院后使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂进行出院治疗与更好的预后相关,而与左心室射血分数无关。
Intern Med J. 2019 Dec;49(12):1505-1513. doi: 10.1111/imj.14289.
4
Risk stratification in heart failure decompensation in the community: HEFESTOS score.社区心力衰竭失代偿的风险分层:HEFESTOS 评分。
ESC Heart Fail. 2022 Feb;9(1):606-613. doi: 10.1002/ehf2.13707. Epub 2021 Nov 22.
5
Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.急性心力衰竭的诱发因素和 90 天转归:来自洲际 GREAT 注册研究的报告。
Eur J Heart Fail. 2017 Feb;19(2):201-208. doi: 10.1002/ejhf.682. Epub 2016 Oct 28.
6
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.射血分数对沙库巴曲缬沙坦(LCZ696)治疗射血分数降低的心力衰竭的疗效及预后的影响:ARNI与ACEI对心力衰竭全球死亡率和发病率影响的前瞻性比较(PARADIGM-HF)试验
Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744.
7
Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).在中东,血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂对左心室收缩功能障碍的急性心力衰竭患者死亡率的影响:来自海湾急性心力衰竭注册研究(Gulf CARE)的观察结果。
Curr Vasc Pharmacol. 2018;16(6):596-602. doi: 10.2174/1570161115666170817164420.
8
Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.左心室功能和心力衰竭症状对心力衰竭患者心房颤动消融术后结局的影响:CASTLE-AF 试验。
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008461. doi: 10.1161/CIRCEP.120.008461. Epub 2020 Sep 9.
9
[Cardiac failure in Chilean hospitals: results of the National Registry of Heart Failure, ICARO].
Rev Med Chil. 2004 Jun;132(6):655-62. doi: 10.4067/s0034-98872004000600001.
10
Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure.功能性电刺激对慢性心力衰竭患者心血管结局的影响。
Eur J Prev Cardiol. 2017 May;24(8):833-839. doi: 10.1177/2047487316687428. Epub 2017 Jan 12.

引用本文的文献

1
A qualitative exploration of the educational needs of people living with heart failure: BANDAIDD-Explore study.心力衰竭患者教育需求的质性探索:BANDAIDD-探索研究
PLoS One. 2025 Feb 7;20(2):e0314059. doi: 10.1371/journal.pone.0314059. eCollection 2025.
2
Health Care Professionals and Data Scientists' Perspectives on a Machine Learning System to Anticipate and Manage the Risk of Decompensation From Patients With Heart Failure: Qualitative Interview Study.医疗保健专业人员和数据科学家对用于预测和管理心力衰竭患者失代偿风险的机器学习系统的看法:定性访谈研究
J Med Internet Res. 2025 Jan 20;27:e54990. doi: 10.2196/54990.
3
Exploring the Relationship Between Ejection Fraction, Arterial Stiffness, NT-proBNP, and Hospitalization Risk in Heart Failure Patients.探索心力衰竭患者射血分数、动脉僵硬度、N末端B型利钠肽原与住院风险之间的关系。
Diagnostics (Basel). 2024 Dec 22;14(24):2885. doi: 10.3390/diagnostics14242885.
4
Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape.射血分数轻度降低和保留的心力衰竭:新治疗格局下的疾病负担及未满足医疗需求综述
Heart Fail Rev. 2024 May;29(3):631-662. doi: 10.1007/s10741-024-10385-y. Epub 2024 Feb 27.
5
Heart failure patients without echocardiography are more commonly diagnosed in hospital care and are associated with higher mortality compared to primary care.心力衰竭患者在医院护理中更常被诊断出来,而不是在初级保健中,且与更高的死亡率相关,而这些患者没有进行超声心动图检查。
Scand J Prim Health Care. 2024 Mar;42(1):29-37. doi: 10.1080/02813432.2023.2283186. Epub 2024 Feb 7.
6
Psychometric Properties of a Machine Learning-Based Patient-Reported Outcome Measure on Medication Adherence: Single-Center, Cross-Sectional, Observational Study.基于机器学习的药物依从性患者报告结局测量的心理测量特性:单中心、横断面、观察性研究。
J Med Internet Res. 2023 Oct 16;25:e42384. doi: 10.2196/42384.
7
Gender-Related Differences in Patients with Acute Heart Failure: Observation from the Journey Heart Failure-Turkish Population Study.急性心力衰竭患者的性别差异:来自 Journey Heart Failure-Turkish 人群研究的观察。
Anatol J Cardiol. 2023 Nov 1;27(11):639-649. doi: 10.14744/AnatolJCardiol.2023.2971. Epub 2023 Jul 19.
8
Prognostic Factors for Prolonged In-Hospital Stay in Patients with Heart Failure.心力衰竭患者住院时间延长的预后因素。
Medicina (Kaunas). 2023 May 12;59(5):930. doi: 10.3390/medicina59050930.
9
Evaluation of the HEFESTOS scale to predict outcomes in emergency department acute heart failure patients.评估 HEFESTOS 量表在急诊科急性心力衰竭患者预后预测中的应用。
Intern Emerg Med. 2022 Oct;17(7):2129-2140. doi: 10.1007/s11739-022-03068-9. Epub 2022 Aug 29.

本文引用的文献

1
Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.在初级保健中心,NT-proBNP 作为射血分数保留和中间范围心力衰竭患者全因死亡率的预后标志物的价值有限:来自瑞典心力衰竭登记处的报告。
Scand J Prim Health Care. 2019 Dec;37(4):434-443. doi: 10.1080/02813432.2019.1684029. Epub 2019 Nov 14.
2
Contact with primary health care physicians before an acute hospitalisation.急性住院前与初级保健医生的接触。
Scand J Prim Health Care. 2019 Sep;37(3):283-293. doi: 10.1080/02813432.2019.1639900. Epub 2019 Jul 9.
3
Disease-specific clinical pathways - are they feasible in primary care? A mixed-methods study.特定疾病临床路径——在初级医疗保健中可行吗?一项混合方法研究。
Scand J Prim Health Care. 2018 Jun;36(2):152-160. doi: 10.1080/02813432.2018.1459167. Epub 2018 Apr 12.
4
Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.基层医疗和医院门诊中射血分数大于或等于40%的心力衰竭患者的合并症、危险因素及预后
Scand J Prim Health Care. 2018 Jun;36(2):207-215. doi: 10.1080/02813432.2018.1459654. Epub 2018 Apr 10.
5
Adherence to guidelines in patients with chronic heart failure in primary health care.基层医疗保健中慢性心力衰竭患者对指南的遵循情况。
Scand J Prim Health Care. 2017 Dec;35(4):336-343. doi: 10.1080/02813432.2017.1397253. Epub 2017 Nov 6.
6
[Precipitating factors in acute heart failure: a review].[急性心力衰竭的诱发因素:综述]
Emergencias. 2017 Jun;29(3):185-193.
7
Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.真实世界中心力衰竭的流行病学与转归:基于88195例患者的人群分析。
PLoS One. 2017 Feb 24;12(2):e0172745. doi: 10.1371/journal.pone.0172745. eCollection 2017.
8
Overdiagnosis of heart failure in primary care: a cross-sectional study.基层医疗中心力衰竭的过度诊断:一项横断面研究。
Br J Gen Pract. 2016 Aug;66(649):e587-92. doi: 10.3399/bjgp16X685705. Epub 2016 Jun 6.
9
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
10
Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.慢性心力衰竭患者的医疗资源利用和支出:基于人群的 88195 例患者分析。
Eur J Heart Fail. 2016 Sep;18(9):1132-40. doi: 10.1002/ejhf.549. Epub 2016 Apr 25.

导致心力衰竭失代偿的诱发因素、在基层医疗机构就诊的心力衰竭患者的短期发病率和死亡率。

Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care.

机构信息

Institut Català de la Salut, Barcelona, Spain.

Unitat de Suport a la Recerca de Barcelona, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.

出版信息

Scand J Prim Health Care. 2020 Dec;38(4):473-480. doi: 10.1080/02813432.2020.1844387. Epub 2020 Nov 17.

DOI:10.1080/02813432.2020.1844387
PMID:33201746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7782727/
Abstract

OBJECTIVE

To evaluate the precipitating factors for heart failure decompensation in primary care and associations with short-term prognosis. Prospective cohort study with a 30-d follow-up from an index consultation. Regression models to determine independent factors associated with hospitalisation or death.

SETTING

Primary care in ten European countries. Patients with diagnosis of heart failure attended in primary care for a heart failure decompensation (increase of dyspnoea, unexplained weight gain or peripheral oedema).

MAIN OUTCOME MEASURES

Potential precipitating factors for decompensation of heart failure and their association with the event of hospitalisation or mortality 30 d after a decompensation.

RESULTS

Of 692 patients 54% were women, mean age 81 (standard deviation [SD] 8.9) years; mean left ventricular ejection fraction (LVEF) 55% (SD 12%). Most frequently identified heart failure precipitation factors were respiratory infections in 194 patients (28%), non-compliance of dietary recommendations in 184 (27%) and non-compliance with pharmacological treatment in 157 (23%). The two strongest precipitating factors to predict 30 d hospitalisation or death were respiratory infections (odds ratio [OR] 2.8, 95% confidence interval [CI] (2.4-3.4)) and atrial fibrillation (AF) > 110 beats/min (OR 2.2, CI 1.5-3.2). Multivariate analysis confirmed the association between the following variables and hospitalisation/death: In relation to precipitating factors: respiratory infection (OR 1.19, 95% CI 1.14-1.25) and AF with heart rate > 110 beats/min (OR 1.22, 95% CI 1.10-1.35); and regarding patient characteristics: New York Heart Association (NYHA) III or IV (OR 1.22, 95% CI 1.15-1.29); previous hospitalisation (OR 1.15, 95% CI 1.11-1.19); and LVEF < 40% (OR 1.14, 95% CI 1.09-1.19).

CONCLUSIONS

In primary care, respiratory infections and rapid AF are the most important precipitating factors for hospitalisation and death within 30 d following an episode of heart failure decompensation. Key points Hospitalisation due to heart failure decompensation represents the highest share of healthcare costs for this disease. So far, no primary care studies have analysed the relationship between precipitating factors and short term prognosis of heart failure decompensation episodes. We found that in 692 patients with heart failure decompensation in primary care, the respiratory infection and rapid atrial fibrillation (AF) increased the risk of short-term hospital admission or death. Patients with a hospital admission the previous year and a decompensation episode caused by respiratory infection were even more likely to be hospitalized or die within 30 d.

摘要

目的

评估初级保健中心心力衰竭失代偿的诱发因素及其与短期预后的关系。

这是一项前瞻性队列研究,对指数就诊后的 30 天进行随访。采用回归模型确定与住院或死亡相关的独立因素。

研究地点

十个欧洲国家的初级保健中心。心力衰竭的诊断患者因心力衰竭失代偿(呼吸困难加重、不明原因体重增加或外周水肿)在初级保健中心就诊。

主要观察指标

心力衰竭失代偿的潜在诱发因素及其与失代偿后 30 天住院或死亡事件的关系。

结果

692 例患者中,54%为女性,平均年龄 81(标准差 8.9)岁;平均左心室射血分数(LVEF)为 55%(标准差 12%)。最常见的心力衰竭诱发因素为 194 例(28%)呼吸道感染、184 例(27%)饮食建议不遵医嘱和 157 例(23%)药物治疗不遵医嘱。预测 30 天住院或死亡的两个最强诱发因素是呼吸道感染(比值比 [OR] 2.8,95%置信区间 [CI](2.4-3.4))和心房颤动(AF)>110 次/分钟(OR 2.2,CI 1.5-3.2)。多变量分析证实了以下变量与住院/死亡之间的关联:与诱发因素有关:呼吸道感染(OR 1.19,95%CI 1.14-1.25)和 AF 心率>110 次/分钟(OR 1.22,95%CI 1.10-1.35);与患者特征有关:纽约心脏协会(NYHA)III 或 IV 级(OR 1.22,95%CI 1.15-1.29);既往住院(OR 1.15,95%CI 1.11-1.19);和 LVEF<40%(OR 1.14,95%CI 1.09-1.19)。

结论

在初级保健中,呼吸道感染和快速性心房颤动是心力衰竭失代偿后 30 天内住院和死亡的最重要诱发因素。

关键点

心力衰竭失代偿导致的住院治疗占该病医疗费用的最大份额。迄今为止,尚无初级保健研究分析心力衰竭失代偿发作的诱发因素与短期预后之间的关系。我们发现,在 692 例因心力衰竭失代偿在初级保健中心就诊的患者中,呼吸道感染和快速性心房颤动(AF)增加了短期住院或死亡的风险。过去一年住院且因呼吸道感染导致失代偿的患者,在 30 天内住院或死亡的风险更高。